Research Article
Impact of Coronary Artery Disease and Percutaneous Coronary Intervention on Transcatheter Aortic Valve Implantation
Table 5
Procedural adverse clinical outcomes in CAD-TAVI group stratified by the performance of PCI.
| | CAD group | PCI group | No PCI group | value PCI versus no PCI | N = 372 | N = 255 | N = 117 |
| Death, N (%) | 11 (3) | 7 (2.8) | 4 (3.4) | 0.75 |
| Significant complications, N(%) | Major or life-threatening bleeding | 14 (3.8) | 12 (4.7) | 2 (1.7) | 0.14 | Minor bleeding | 14 (3.8) | 10 (4) | 4 (3.4) | 0.78 | Major vascular complication | 17 (4.6) | 13 (5.1) | 4 (3.4) | 0.44 | Minor vascular complication | 25 (6.7) | 15 (5.9) | 10 (8.4) | 0.37 | Stroke | 9 (2.4) | 6 (2.4) | 3 (2.5) | 0.93 | Acute kidney injury | 8 (2.2) | 4 (1.6) | 4 (3.4) | 0.27 | Pacemaker implantation | 51 (13.7) | 33 (13) | 18 (15.1) | 0.58 |
| CCU admission, N (%) | 212 (57) | 134 (53) | 78 (65.5) | 0.22 |
|
|
CAD = coronary artery disease. PCI = percutaneous coronary intervention. CCU = cardiac care unit. |